Novavax, Inc.Gaithersburg, Maryland, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
LB746 - Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States
Thursday, October 20, 20221:57 PM - 2:09 PM US ET